During the past decade, Nucleus Network, Ltd. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nucleus Network, Ltd." #1 sponsor was "Gilead Sciences" with 4 trials, followed by "Arrowhead Pharmaceuticals" with 3 trials sponsored, "Arch Biopartners Inc." with 1 trials sponsored, "Neurovance, Inc." with 1 trials sponsored and "Noxopharm Limited" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nucleus Network, Ltd." #1 collaborator was "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Nucleus Network, Ltd." are "Cystic Fibrosis" (4 trials), "Mucociliary Clearance" (3 trials), "Airway Hydration" (2 trials), "Advanced Solid Tumours" (1 trials) and "Alpha-1 Antitrypsin Deficiency" (1 trials). Many other conditions were trialed in "Nucleus Network, Ltd." in a lesser frequency.

Most popular intervention types in "Nucleus Network, Ltd." are "Drug" (12 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "GS-9411" (4 trials), "0.9% Saline" (1 trials), "ARC-520" (1 trials) and "ARC-520 Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nucleus Network, Ltd." are 10 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Nucleus Network, Ltd.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Nucleus Network, Ltd., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nucleus Network, Ltd., 9 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".